Attractive stocks have exceptional fundamentals. In the case of Trulieve Cannabis Corp. (CNSX:TRUL), there’s is a company with robust financial health as well as an optimistic growth outlook. In the following section, I expand a bit more on these key aspects. For those interested in digger a bit deeper into my commentary, take a look at the report on Trulieve Cannabis here.
High growth potential with excellent balance sheet
TRUL is an attractive stock for growth-seeking investors, with an expected earnings growth of 34% in the upcoming year. Earnings growth is paired with an eye-catching top-line trajectory also doubling over the same period, which indicates a high-quality bottom-line expansion, as opposed to those driven by unsustainable cost-cutting activities. TRUL is financially robust, with ample cash on hand and short-term investments to meet upcoming liabilities. This indicates that TRUL has sufficient cash flows and proper cash management in place, which is a key determinant of the company’s health. TRUL’s has produced operating cash levels of 1.19x total debt over the past year, which implies that TRUL’s management has put its borrowings into good use by generating enough cash to cover a sufficient portion of borrowings.
For Trulieve Cannabis, I’ve compiled three relevant aspects you should further research:
- Historical Performance: What has TRUL’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
- Valuation: What is TRUL worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether TRUL is currently mispriced by the market.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of TRUL? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at firstname.lastname@example.org. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.